B-cell Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS safety_alert · 2024-08-21
Clinical Trial Update: Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies
This clinical trial update discusses the use of BTK inhibitors ibrutinib and acalabrutinib and the associated risk of atrial fibrillation in…